loading
Schlusskurs vom Vortag:
$7.23
Offen:
$7.16
24-Stunden-Volumen:
18,814
Relative Volume:
0.09
Marktkapitalisierung:
$690.99M
Einnahmen:
$106.66M
Nettoeinkommen (Verlust:
$15.16M
KGV:
79.41
EPS:
0.0935
Netto-Cashflow:
$6.37M
1W Leistung:
+0.20%
1M Leistung:
-4.44%
6M Leistung:
-29.95%
1J Leistung:
-51.28%
1-Tages-Spanne:
Value
$7.16
$7.48
1-Wochen-Bereich:
Value
$7.09
$7.63
52-Wochen-Spanne:
Value
$6.11
$19.00

Gyre Therapeutics Inc Stock (GYRE) Company Profile

Name
Firmenname
Gyre Therapeutics Inc
Name
Telefon
(619) 949-3681
Name
Adresse
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Name
Mitarbeiter
574
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
GYRE's Discussions on Twitter

Vergleichen Sie GYRE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GYRE
Gyre Therapeutics Inc
7.37 649.10M 106.66M 15.16M 6.37M 0.0935
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.48 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.19 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.25 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.21 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.50 29.19B 3.81B -644.79M -669.77M -6.24

Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-11 Eingeleitet Noble Capital Markets Outperform
2021-04-29 Fortgesetzt Stephens Overweight
2021-02-10 Eingeleitet Piper Sandler Overweight
2020-05-21 Eingeleitet Raymond James Outperform
2019-01-04 Eingeleitet Oppenheimer Outperform
2018-02-12 Bestätigt B. Riley FBR, Inc. Buy
2018-02-09 Bestätigt Chardan Capital Markets Buy
2017-12-08 Eingeleitet B. Riley FBR, Inc. Buy
2017-06-12 Eingeleitet Chardan Capital Markets Buy
2017-06-06 Eingeleitet Ladenburg Thalmann Buy
2016-06-30 Eingeleitet Rodman & Renshaw Buy
Alle ansehen

Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten

pulisher
07:38 AM

What analysts say about Gyre Therapeutics Inc. stockExceptional profit velocity - Autocar Professional

07:38 AM
pulisher
Jul 22, 2025

Gyre Therapeutics Inc. Stock Analysis and ForecastHigh-yield capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Gyre Therapeutics Inc. stock priceOutperformance with explosive growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is GEOS a good long term investmentStrong return on assets - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What drives LVRO stock priceFree Consultation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 17:00:56 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives UWMC.WS stock priceSuperior investment outcomes - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Best Stocks for Dividend Growth in India Trusted Investment GroupFree Market Dynamics Reports - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Stocks with the Best Technical Indicators in India Intelligent Investment DecisionsExceptional earning trajectories - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Is LCUT a good long term investmentRemarkably fast returns - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Can Confidence Petroleum India Limited (526829) Maintain Its ValuationFree Stock Market Beginners Guide - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

What drives Delta Air Lines Inc. stock priceHigh-velocity capital appreciation - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

D India Limited (522275) Sees Unusual Trading VolumeSuperior returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Best Real Estate Stocks AI Driven Market StrategiesFree Consultation - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Is Gyre Therapeutics Inc. a good long term investmentOver 200% growth - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Will Gyre Therapeutics Inc. stock benefit from AI tech trendsFree Professional Trading Signals - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Will ADSEW stock benefit from AI tech trendsTop Momentum Stock Pick - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Why Gyre Therapeutics Inc. stock attracts strong analyst attentionFree Day Trading Recommendations - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

What makes USCB stock price move sharplyFree Stock Market Query - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes AerCap Holdings N.V. stock price move sharplyFast Moving Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Gyre Therapeutics Inc. stock price move sharplyLong Term Secure Gain Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes AMTD Digital Inc. Depositary Receipt stock price move sharplyPortfolio Boosting Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Weyco Group Inc. stock performs during market volatilityWatchlist Winner Update - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why CO2 Energy Transition Corp. stock attracts strong analyst attentionEarly Buy Suggestion - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Gyre Therapeutics Inc. stock performs during market volatilityInstant Stock Updates - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How 4D Molecular Therapeutics Inc. stock performs during market volatilityFree Stock Market Forecasting Tools - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How ASB.PRF stock performs during market volatilityElite Investor Club - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes ABCL stock price move sharplySolid Return Trade Selections - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How High Can LDO(lidodaotoken) GoFree VIP Group - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Head to Head Analysis: Gyre Therapeutics (NASDAQ:GYRE) versus Entera Bio (NASDAQ:ENTX) - Defense World

Jul 09, 2025
pulisher
Jun 30, 2025

Gyre Therapeutics, Inc.(NasdaqCM: GYRE) dropped from Russell 3000 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 13, 2025

Gyre Therapeutics, Inc. (GYRE) Raises $23M in Public Stock Offering to Fund Liver Fibrosis Trials - MSN

Jun 13, 2025
pulisher
Jun 10, 2025

Gyre Therapeutics announces first doing in Phase 1 trial of F230 - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

Gyre Therapeutics (GYRE) Begins Phase 1 Trial for Pulmonary Hypertension Drug | GYRE Stock News - GuruFocus

Jun 10, 2025

Finanzdaten der Gyre Therapeutics Inc-Aktie (GYRE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Gyre Therapeutics Inc-Aktie (GYRE) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Ma Songjiang
President
May 28 '25
Sale
10.07
558
5,619
2,806,084
Ma Songjiang
President
May 22 '25
Sale
10.97
2,000
21,940
2,808,824
Ma Songjiang
President
May 23 '25
Sale
10.24
182
1,864
2,808,642
Ma Songjiang
President
May 20 '25
Sale
11.25
2,000
22,500
2,812,824
Ma Songjiang
President
May 21 '25
Sale
10.83
2,000
21,660
2,810,824
Ma Songjiang
President
May 16 '25
Sale
11.31
2,000
22,620
2,816,824
Ma Songjiang
President
May 19 '25
Sale
11.11
2,000
22,220
2,814,824
Ma Songjiang
President
May 15 '25
Sale
10.68
2,000
21,360
2,818,824
Ma Songjiang
President
May 14 '25
Sale
11.30
20
226
2,820,824
Ye Weiguo
Chief Operating Officer
Apr 01 '25
Option Exercise
0.75
50,000
37,500
700,000
$22.80
price up icon 4.56%
$36.00
price down icon 0.33%
$102.46
price down icon 0.38%
$27.75
price up icon 4.50%
$113.56
price up icon 1.86%
biotechnology ONC
$295.32
price down icon 0.11%
Kapitalisierung:     |  Volumen (24h):